<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0005">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="lis0005">
   <list-item id="lsti0005">
    <label>•</label>
    <p id="par0005">There is limited data on the novel coronavirus respiratory illness (COVID-19) in patients with cancer.</p>
   </list-item>
   <list-item id="lsti0010">
    <label>•</label>
    <p id="par0010">COVID-19 diffusion in cancer patients is not prominent as expected, rather seems as contagious as for the general population.</p>
   </list-item>
   <list-item id="lsti0015">
    <label>•</label>
    <p id="par0015">There is no clear role for immune-suppression as an additional risk factor for coronavirus infection.</p>
   </list-item>
   <list-item id="lsti0020">
    <label>•</label>
    <p id="par0020">The pathogenicity of COVID-19 is exacerbated by the host’s immune system’s reaction.</p>
   </list-item>
   <list-item id="lsti0025">
    <label>•</label>
    <p id="par0025">Patients receiving immunotherapy may be more at risk for an aberrant response in case of infection.</p>
   </list-item>
  </list>
 </p>
</abstract>
